Literature DB >> 9783483

Cardiovascular risk factors in the elderly.

E Casiglia1, P Palatini.   

Abstract

Although a number of risk factors for cardiovascular morbidity and mortality have been identified in young and middle-aged adults, their prevalence and importance are less known in the elderly. Elderly people have a risk profile different from that of younger subjects, but representative data on risk factors for cardiovascular disease in the elderly are difficult to find in the literature. Some typical 'major' risk factors, like blood pressure (BP), total cholesterol or left ventricular hypertrophy, do not have a clear predictive role for cardiovascular mortality in the elderly, especially in the extreme ages, while risk indicators usually labelled as 'minor' (serum uric acid, ventilatory function or proteinuria), do have a strong predictive value in these individuals. This must be taken into account when evaluating the cumulative risk of the elderly, in order to avoid overtreatment of subjects with mildly elevated BP or cholesterol.

Entities:  

Mesh:

Year:  1998        PMID: 9783483     DOI: 10.1038/sj.jhh.1000668

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  10 in total

1.  Smooth blood pressure control obtained with extended-release felodipine in elderly patients with hypertension: evaluation by 24-hour ambulatory blood pressure monitoring.

Authors:  Roberto Antonicelli; Stefano Omboni; Di Ciò Giovanni; Roberto Ansuini; Alfredo Mori; Rosaria Gesuita; Gianfranco Parati; Enrico Paciaroni
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

2.  Prevalence of cardiovascular risk factors among rural population of elderly in Wardha district.

Authors:  Rajnish Joshi; Bharti Taksande; Shri Prakash Kalantri; Ulhas Narayan Jajoo; Rajeev Gupta
Journal:  J Cardiovasc Dis Res       Date:  2013-06-19

3.  Old-style epidemiology and epigeneticdemiology.

Authors:  Edoardo Casiglia; Valérie Tikhonoff
Journal:  Hypertens Res       Date:  2015-03-26       Impact factor: 3.872

4.  Soluble tumor necrosis factor receptors and heart failure risk in older adults: Health, Aging, and Body Composition (Health ABC) Study.

Authors:  Catherine N Marti; Hassan Khan; Douglas L Mann; Vasiliki V Georgiopoulou; Kirsten Bibbins-Domingo; Tamara Harris; Annemarie Koster; Anne Newman; Stephen B Kritchevsky; Andreas P Kalogeropoulos; Javed Butler
Journal:  Circ Heart Fail       Date:  2013-12-09       Impact factor: 8.790

5.  C-reactive protein and lipid parameters in older persons aged 80 years and older.

Authors:  M Cesari; G Onder; V Zamboni; E Capoluongo; A Russo; R Bernabei; M Pahor; F Landi
Journal:  J Nutr Health Aging       Date:  2009-08       Impact factor: 4.075

6.  Electrocardiographic criteria of left ventricular hypertrophy in general population.

Authors:  Edoardo Casiglia; Laura Schiavon; Valérie Tikhonoff; Anna Bascelli; Bortolo Martini; Alberto Mazza; Sandro Caffi; Daniele D'Este; Francesco Bagato; Monica Bolzon; Federica Guidotti; Hilda Haxhi Nasto; Mario Saugo; Francesco Guglielmi; Achille C Pessina
Journal:  Eur J Epidemiol       Date:  2008-03-06       Impact factor: 8.082

7.  Cognitive functions and cognitive reserve in relation to blood pressure components in a population-based cohort aged 53 to 94 years.

Authors:  Nunzia Giordano; Valérie Tikhonoff; Paolo Palatini; Anna Bascelli; Giovanni Boschetti; Fabia De Lazzari; Carla Grasselli; Bortolo Martini; Sandro Caffi; Antonio Piccoli; Alberto Mazza; Patrizia Bisiacchi; Edoardo Casiglia
Journal:  Int J Hypertens       Date:  2012-04-04       Impact factor: 2.420

8.  Biomarkers versus traditional risk factors to predict cardiovascular events in very old adults: cross-validated prospective cohort study.

Authors:  Bert Vaes; Paulien Indestege; Tinne Serneels; Eralda Hegendörfer; Petra G van Peet; Rosalinde K E Poortvliet; Pierre Wallemacq; Jacobijn Gussekloo; Jan Degryse
Journal:  BMJ Open       Date:  2020-06-28       Impact factor: 2.692

9.  Serum uric acid and fatal myocardial infarction: detection of prognostic cut-off values: The URRAH (Uric Acid Right for Heart Health) study.

Authors:  Edoardo Casiglia; Valérie Tikhonoff; Agostino Virdis; Stefano Masi; Carlo M Barbagallo; Michele Bombelli; Bernardino Bruno; Arrigo F G Cicero; Massimo Cirillo; Pietro Cirillo; Giovambattista Desideri; Lanfranco D'Elia; Claudio Ferri; Ferruccio Galletti; Loreto Gesualdo; Cristina Giannattasio; Guido Iaccarino; Luciano Lippa; Francesca Mallamaci; Alessandro Maloberti; Alberto Mazza; Maria Lorenza Muiesan; Pietro Nazzaro; Paolo Palatini; Gianfranco Parati; Roberto Pontremoli; Fosca Quarti-Trevano; Marcello Rattazzi; Giulia Rivasi; Massimo Salvetti; Giuliano Tocci; Andrea Ungar; Paolo Verdecchia; Francesca Viazzi; Massimo Volpe; Guido Grassi; Claudio Borghi
Journal:  J Hypertens       Date:  2020-03       Impact factor: 4.776

10.  The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases.

Authors:  J Danesh; S Erqou; M Walker; S G Thompson; R Tipping; C Ford; S Pressel; G Walldius; I Jungner; A R Folsom; L E Chambless; M Knuiman; P H Whincup; S G Wannamethee; R W Morris; J Willeit; S Kiechl; P Santer; A Mayr; N Wald; S Ebrahim; D A Lawlor; J W G Yarnell; J Gallacher; E Casiglia; V Tikhonoff; P J Nietert; S E Sutherland; D L Bachman; J E Keil; M Cushman; B M Psaty; R P Tracy; A Tybjaerg-Hansen; B G Nordestgaard; R Frikke-Schmidt; S Giampaoli; L Palmieri; S Panico; D Vanuzzo; L Pilotto; L Simons; J McCallum; Y Friedlander; F G R Fowkes; A J Lee; F B Smith; J Taylor; J Guralnik; C Phillips; R Wallace; D Blazer; K T Khaw; J H Jansson; C Donfrancesco; V Salomaa; K Harald; P Jousilahti; E Vartiainen; M Woodward; R B D'Agostino; P A Wolf; R S Vasan; M J Pencina; E M Bladbjerg; T Jorgensen; L Moller; J Jespersen; R Dankner; A Chetrit; F Lubin; A Rosengren; L Wilhelmsen; G Lappas; H Eriksson; C Bjorkelund; P Cremer; D Nagel; R Tilvis; T Strandberg; B Rodriguez; L M Bouter; R J Heine; J M Dekker; G Nijpels; C D A Stehouwer; E Rimm; J Pai; S Sato; H Iso; A Kitamura; H Noda; U Goldbourt; V Salomaa; J T Salonen; K Nyyssönen; T-P Tuomainen; D Deeg; J L Poppelaars; T Meade; J Cooper; B Hedblad; G Berglund; G Engstrom; A Döring; W Koenig; C Meisinger; W Mraz; L Kuller; R Selmer; A Tverdal; W Nystad; R Gillum; M Mussolino; S Hankinson; J Manson; B De Stavola; C Knottenbelt; J A Cooper; K A Bauer; R D Rosenberg; S Sato; Y Naito; I Holme; H Nakagawa; H Miura; P Ducimetiere; X Jouven; C Crespo; M Garcia-Palmieri; P Amouyel; D Arveiler; A Evans; J Ferrieres; H Schulte; G Assmann; J Shepherd; C Packard; N Sattar; B Cantin; B Lamarche; J-P Després; G R Dagenais; E Barrett-Connor; D Wingard; R Bettencourt; V Gudnason; T Aspelund; G Sigurdsson; B Thorsson; M Trevisan; J Witteman; I Kardys; M Breteler; A Hofman; H Tunstall-Pedoe; R Tavendale; G D O Lowe; Y Ben-Shlomo; B V Howard; Y Zhang; L Best; J Umans; A Onat; T W Meade; I Njolstad; E Mathiesen; M L Lochen; T Wilsgaard; J M Gaziano; M Stampfer; P Ridker; H Ulmer; G Diem; H Concin; F Rodeghiero; A Tosetto; E Brunner; M Shipley; J Buring; S M Cobbe; I Ford; M Robertson; Y He; A M Ibanez; E J M Feskens; D Kromhout; R Collins; E Di Angelantonio; S Kaptoge; S Lewington; L Orfei; L Pennells; P Perry; K Ray; N Sarwar; M Scherman; A Thompson; S Watson; F Wensley; I R White; A M Wood
Journal:  Eur J Epidemiol       Date:  2007-09-18       Impact factor: 8.082

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.